ArticleCell chemical biology2018

Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer.

Teresa Kaserer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.